MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Adenomatous Polyps

(UMLS:C0206677)

Definition:: Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed)
UMLS ID:: C0206677
MeSH ID:: D018256

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.035.215

Synonym(s)

Adenomatous Polyps

Adenomatous Polyp

Adenomatous polyp

Adenomatous polyp NOS

Adenomatous polyp, NOS

POLYP ADENOMATOUS

Polypoid Adenoma

Polypoid adenoma

adenomatous polyp

10.

adenomatous polyps

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Cyproterone Acetate	8706251	CTD
2	Formaldehyde	12562630	CTD
3	Piroxicam	10213222	CTD
4	Sulindac	10213222	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Adenomatosis, Pulmonary	48.4%
2	Cystadenoma	47.3%
3	Mesothelioma	47.3%
4	Carcinoma	34.4%
5	Epithelioma	34.4%
6	Adenoma, Acidophil	31.2%
7	Basal cell carcinoma	30.1%
8	Carcinoma, Papillary	30.1%
9	Squamous cell carcinoma	30.1%
10	Carcinoma, Basal Cell	30.1%
11	Neoplasms, Neuroepithelial	26.8%
12	Gliomatosis cerebri	26.8%
13	Cystadenocarcinoma	26.2%
14	Mucoepidermoid Carcinoma	26.2%
15	leukemia	25.4%
16	Neoplasms, Germ Cell and Embryonal	25.4%
17	Germ Cell Cancer	25.4%
18	Adenocarcinoma	22.6%
19	Carcinoma in Situ	22.6%
20	Carcinoma, Transitional Cell	22.6%
21	Papilloma	22.6%
22	Pseudomyxoma Peritonei	22.6%
23	Papillomatosis	22.6%
24	Carcinoma, Large Cell	22.6%
25	Carcinoma, Small Cell	22.6%
26	Bowen's Disease	22.3%
27	Carcinoma, Ehrlich Tumor	21.1%
28	Carcinoma, Lewis Lung	21.1%
29	Hepatocellular Adenoma	20.9%
30	Neuroectodermal Tumors	19.8%
31	Adenofibroma	18.9%
32	Fibroadenoma	18.9%
33	Acanthoma	18.5%
34	Ganglioneuroma	18.4%
35	Glioma	18.4%
36	Malignant Glioma	18.4%
37	Carcinoma, Lobular	17.8%
38	Prolactinoma	17.3%
39	Growth Hormone-Secreting Pituitary Adenoma	17.3%
40	Histiocytic Disorders, Malignant	16.9%
41	Adenoid Cystic Carcinoma	16.8%
42	Adenocarcinoma, Clear Cell	16.8%
43	Cholangiocarcinoma	16.8%
44	Cervical Intraepithelial Neoplasia	16.8%
45	Hamartoma	16.4%
46	Neoplasms, Hormone-Dependent	16.4%
47	Neoplasms, Multiple Primary	16.4%
48	Paraneoplastic Syndromes	16.4%
49	Precancerous Conditions	16.4%
50	Neoplasms, Second Primary	16.4%
51	Carcinosarcoma	16.3%
52	Hemangiosarcoma	16.3%
53	lymphangiosarcoma	16.3%
54	Medulloblastoma	16.3%
55	Carcinoid Tumor	15.5%
56	Ameloblastoma	14.8%
57	Angiokeratoma	14.8%
58	Chordoma	14.8%
59	Hemangioma	14.8%
60	hemangiopericytoma	14.8%
61	Lymphangioma	14.8%
62	Mesenchymoma	14.8%
63	Nevus	14.8%
64	Teratoma	14.8%
65	Hepatoblastoma	14.8%
66	Mixed Tumor, Mullerian	14.8%
67	Germinoma	14.8%
68	Teratocarcinoma	14.8%
69	Angiofibroma	14.8%
70	Sarcoma	14.8%
71	melanoma	14.5%
72	Astrocytoma	14.3%
73	Ependymoma	14.3%
74	oligodendroglioma	14.3%
75	Ganglioglioma	14.3%
76	gliosarcoma	14.3%
77	Anaplastic astrocytoma	14.3%
78	Anaplastic Oligodendroglioma	14.3%
79	Klatskin Tumor	13.9%
80	Chondrosarcoma	12.9%
81	Craniopharyngioma	12.9%
82	leiomyosarcoma	12.9%
83	liposarcoma	12.9%
84	synovial sarcoma	12.9%
85	Neuroectodermal Tumor, Melanotic	12.9%
86	Angiomyolipoma	12.9%
87	Clear Cell Sarcoma of Soft Tissue	12.9%
88	Alveolar Soft Part Sarcoma	12.9%
89	Neuroendocrine Tumors	12.9%
90	Sarcoma, Myeloid	12.9%
91	Malignant Carcinoid Syndrome	12.9%
92	Carcinoma 256, Walker	12.8%
93	Meningioma	12.7%
94	Choriocarcinoma	12.6%
95	Lymphoma	12.6%
96	Glioblastoma	12.3%
97	Neuroblastoma	12.3%
98	Glioblastoma Multiforme	12.3%
99	Dermoid Cyst	12.2%
100	Leukemia, Plasma Cell	12.2%
101	Trophoblastic Neoplasms	11.8%
102	Composite Lymphoma	11.8%
103	insulinoma	11.7%
104	Leukemia, Experimental	11.7%
105	Ganglioneuroblastoma	11.2%
106	Fibrosarcoma	11.2%
107	Osteosarcoma	11.2%
108	Cyst	10.8%
109	Neoplastic Processes	10.8%
110	Neoplastic Syndromes, Hereditary	10.8%
111	Pregnancy Complications, Neoplastic	10.8%
112	Neurilemmoma	10.8%
113	Hutchinson's Melanotic Freckle	10.8%
114	Melanoma, Amelanotic	10.8%
115	Neoplasms, Experimental	10.6%
116	Malignant Fibrous Histiocytoma	10.4%
117	Retinoblastoma	10.2%
118	Melanoma, Experimental	10%
119	Plasmacytoma	9.9%
120	Malignant histiocytosis	9.8%
121	Leukemia L1210	9.8%
122	Leukemia P388	9.8%
123	Histiocytic sarcoma	9.8%
124	Phyllodes Tumor	9.7%
125	Dysgerminoma	9.7%
126	Hemangioendothelioma	9.7%
127	Lipoma	9.7%
128	Myoma	9.7%
129	Myxoma	9.7%
130	Neuroma	9.7%
131	Seminoma	9.7%
132	Angiolipoma	9.7%
133	Myelolipoma	9.7%
134	Neoplasms, Bone Tissue	9.7%
135	Neoplasms, Fibrous Tissue	9.7%
136	Smooth Muscle Tumor	9.7%
137	Desmoplastic Small Round Cell Tumor	9.7%
138	Chondroma	9.7%
139	Enchondroma	9.7%
140	Paraganglioma	9.6%
141	Rhabdomyosarcoma	9.6%
142	Giant Cell Tumor of Bone	9.6%
143	Leukemia, Radiation-Induced	9.5%
144	Carcinoid Heart Disease	9.5%
145	Carcinoma, Pancreatic Ductal	9.4%
146	Sarcoma, Experimental	9.1%
147	Thymoma	9%
148	Basal Cell Nevus Syndrome	9%
149	Dermatofibrosarcoma	8.8%
150	Dermatofibrosarcoma Protuberans	8.8%
151	Endometrial Stromal Sarcoma	8.6%
152	Abdominal Neoplasms	8.5%
153	Erythroplasia	8.5%
154	Follicular cyst	8.5%
155	Head and Neck Neoplasms	8.5%
156	Mucocele	8.5%
157	Pilonidal Cyst	8.5%
158	Soft Tissue Neoplasms	8.5%
159	Thoracic Neoplasms	8.5%
160	Thyroglossal Cyst	8.5%
161	Synovial Cyst	8.5%
162	Aberrant Crypt Foci	8.5%
163	Sarcoma 180	8.1%
164	Pheochromocytoma	7.9%
165	Alveolar rhabdomyosarcoma	7.9%
166	Neoplasms, Radiation-Induced	7.9%
167	Lymphangioleiomyomatosis	7.7%
168	Multiple Endocrine Neoplasia	7.4%
169	Carcinoma, Ovarian Epithelial	7.4%
170	Hodgkin Disease	7.3%
171	Lymphoma, Non-Hodgkin	7.3%
172	fibroma	7.2%
173	Fibromatosis	7.2%
174	Osteoblastoma	7.2%
175	Osteoma	7.2%
176	Rhabdomyoma	7.2%
177	Chondromatosis	7.2%
178	Hemangioblastoma	7.2%
179	Lymphoma, Extranodal NK-T-Cell	7.2%
180	Paraneoplastic Encephalomyelitis	6.8%
181	Neurofibrosarcoma	6.7%
182	Mammary Neoplasms, Experimental	6.7%
183	Leukemia, Myelomonocytic, Chronic	6.5%
184	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	6.5%
185	Adrenocortical carcinoma	6.4%
186	Vipoma	6.2%
187	Lymphomatoid Granulomatosis	6.2%
188	Nasopharyngeal carcinoma	6.1%
189	Optic Nerve Glioma	6%
190	Digestive System Neoplasms	6%
191	Endocrine Gland Neoplasms	6%
192	Eye Neoplasms	6%
193	Nervous System Neoplasms	6%
194	Fibromatosis, Aggressive	6%
195	Fibromatosis, Abdominal	6%
196	Primary amyloidosis	5.9%
197	Bone neoplasms	5.7%
198	Leukoplakia	5.7%
199	Lymphocele	5.7%
200	Pancreatic Cyst	5.7%
201	Skin Neoplasms	5.7%
202	Hematologic Neoplasms	5.7%
203	Nephroblastoma	5.6%
204	Barrett Esophagus	5.6%
205	Breast Cyst	5.6%
206	Actinic keratosis	5.6%
207	Mediastinal Cyst	5.6%
208	Neoplasm Invasiveness	5.6%
209	Neoplasm Metastasis	5.6%
210	Neoplasm Recurrence, Local	5.6%
211	Parovarian Cyst	5.6%
212	Pericardial Cyst	5.6%
213	Splenic Neoplasms	5.6%
214	Thymic Cyst	5.6%
215	Carcinogenesis	5.6%
216	Myxoid cyst	5.6%
217	Metastasis	5.6%
218	Renal Cell Carcinoma	5.5%
219	Papillary Renal Cell Carcinoma	5.5%
220	Gastrinoma	5.4%
221	Glucagonoma	5.4%
222	Carcinoma, Endometrioid	5.3%
223	Hydatidiform Mole	5.2%
224	Tuberous Sclerosis	5.1%
225	Mastocytosis	5%
226	Sturge-Weber Syndrome	5%
227	Retroperitoneal Neoplasms	4.9%
228	Gastrointestinal Stromal Tumors	4.9%
229	Hemangioma, Cavernous	4.9%
230	Mastocytoma	4.9%
231	Leukemia, T-Cell	4.8%
232	Leukemia, B-Cell	4.8%
233	Mesoblastic Nephroma	4.8%
234	neurofibroma	4.8%
235	Mastocytosis, Systemic	4.8%
236	Lymphoma, Follicular	4.8%
237	T-Cell Lymphoma	4.8%
238	Mantle cell lymphoma	4.8%
239	Acoustic Neuroma	4.8%
240	Leukemia, Myeloid, Chronic-Phase	4.8%
241	Multiple Endocrine Neoplasia Type 1	4.4%
242	Waldenstrom Macroglobulinemia	4.2%
243	Multiple Myeloma	4.2%
244	Corpus Luteum Cyst	4.1%
245	Ovarian Cysts	4.1%
246	Parathyroid Neoplasms	4.1%
247	Peritoneal Neoplasms	4.1%
248	Thyroid Neoplasm	4.1%
249	Thyroid carcinoma	4.1%
250	Liver Neoplasms, Experimental	3.9%
251	granulosa cell tumor	3.7%
252	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
253	Leukemia, Large Granular Lymphocytic	3.6%
254	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
255	Lymphoma, T-Cell, Cutaneous	3.6%
256	Lymphoma, AIDS-Related	3.6%
257	Enteropathy-Associated T-Cell Lymphoma	3.6%
258	Primary Effusion Lymphoma	3.6%
259	Pancreatic Neoplasm	3.4%
260	Choledochal Cyst	3.4%
261	Tracheal Neoplasms	3.4%
262	Mouth Neoplasms	3.4%
263	Central Nervous System Neoplasms	3.4%
264	Vascular Neoplasms	3.4%
265	Thymus Neoplasms	3.4%
266	Genital Neoplasms, Female	3.3%
267	Pancreatic Pseudocyst	3.3%
268	Peutz-Jeghers Syndrome	3.3%
269	Leukoplakia, Oral	3.3%
270	Paraneoplastic Cerebellar Degeneration	3.3%
271	Lymphatic Metastasis	3.3%
272	Neoplasms, Unknown Primary	3.3%
273	Leukemic Infiltration	3.3%
274	Breast Neoplasms, Male	3.3%
275	Neoplasm Micrometastasis	3.3%
276	Triple Negative Breast Neoplasms	3.3%
277	Dupuytren Contracture	3.1%
278	Urticaria Pigmentosa	3%
279	Mycosis Fungoides	3%
280	Lymphomatoid Papulosis	3%
281	Plasmablastic lymphoma	3%
282	Leydig Cell Tumor	2.9%
283	Esophageal Neoplasms	2.7%
284	Limbic Encephalitis	2.7%
285	Thyroid Nodule	2.6%
286	Adrenal Gland Neoplasms	2.6%
287	Gastrointestinal Neoplasms	2.6%
288	Genital Neoplasms, Male	2.6%
289	Liver neoplasms	2.6%
290	Uveal Neoplasms	2.6%
291	Denys-Drash Syndrome	2.5%
292	Urologic Neoplasms	2.5%
293	Sebaceous Gland Neoplasms	2.5%
294	Spinal Neoplasms	2.5%
295	Bone Marrow Neoplasms	2.5%
296	Polycystic Ovary Syndrome	2.4%
297	Burkitt Lymphoma	2.4%
298	Lambert-Eaton Myasthenic Syndrome	2.4%
299	Testicular Neoplasms	2.4%
300	Meningeal Neoplasms	2.2%
301	Opsoclonus-Myoclonus Syndrome	2.1%
302	Adenomatous Polyposis Coli	2%
303	Sezary Syndrome	2%
304	Xeroderma Pigmentosum	1.9%
305	Myelitis, Transverse	1.8%
306	Ear Neoplasms	1.7%
307	Eyelid Neoplasms	1.7%
308	Lung Neoplasms	1.7%
309	Nose Neoplasms	1.7%
310	Pleural Neoplasms	1.7%
311	ovarian neoplasm	1.7%
312	Cell Transformation, Viral	1.6%
313	Brain Neoplasms	1.6%
314	Salivary Gland Neoplasms	1.6%
315	Spinal Cord Neoplasms	1.6%
316	Tongue Neoplasms	1.6%
317	Palatal Neoplasms	1.6%
318	Uterine Neoplasms	1.6%
319	Vaginal Neoplasms	1.6%
320	Vulvar Neoplasms	1.6%
321	Uterine Cancer	1.6%
322	Fallopian Tube Neoplasms	1.6%
323	Meningeal Carcinomatosis	1.6%
324	Pituitary Adenoma	1.5%
325	Pituitary Neoplasms	1.5%
326	Pharyngeal Neoplasms	1.4%
327	Central Nervous System Cysts	1.3%
328	Bile Duct Neoplasms	1.3%
329	gallbladder neoplasm	1.3%
330	Intestinal Neoplasms	1.3%
331	Penile Neoplasms	1.3%
332	Prostatic Neoplasms	1.3%
333	Stomach Neoplasms	1.3%
334	Polycythemia Vera	1.3%
335	Bronchial Neoplasms	1.2%
336	Zollinger-Ellison syndrome	1.2%
337	Multiple Pulmonary Nodules	1.2%
338	Supratentorial Neoplasms	1.2%
339	Endometrial Neoplasms	1.2%
340	Laryngeal neoplasm	1.1%
341	Bladder Neoplasm	1.1%
342	Kidney Neoplasm	1.1%
343	Ureteral Neoplasms	1.1%
344	Urethral Neoplasms	1.1%
345	Brain Stem Neoplasms	1%
346	Hypopharyngeal Neoplasms	1%
347	Pleural Effusion, Malignant	1%
348	Hypopharyngeal Cancer	1%
349	Parotid Neoplasms	1%
350	Prostatic Neoplasms, Castration-Resistant	1%
351	Nelson Syndrome	1%
352	Choroid Plexus Papilloma	0.9%
353	Cecal Neoplasms	0.8%
354	Duodenal Neoplasms	0.8%
355	Tonsillar Neoplasms	0.8%
356	Cerebellar Neoplasms	0.8%
357	Nasopharyngeal Neoplasms	0.7%
358	Colorectal Neoplasms	0.7%
359	Radicular Cyst	0.7%
360	Appendiceal Neoplasms	0.7%
361	Colonic Neoplasms	0.7%
362	Rectal Neoplasms	0.7%
363	Paranasal Sinus Neoplasms	0.6%
364	Anus Neoplasms	0.5%
365	Sigmoid Neoplasms	0.5%
366	Maxillary Sinus Neoplasms	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234